Publications by authors named "Kevin Mullane"

Claim this Profile
A
Alzheimer's disease beyond amyloid: Can the repetitive failures of amyloid-targeted therapeutics inform future approaches to dementia drug discovery?
Kevin Mullane, Michael Williams

Biochem Pharmacol· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preclinical Models of Alzheimer's Disease: Relevance and Translational Validity.
Kevin Mullane, Michael Williams

Curr Protoc Pharmacol· March 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The de-Alzheimerization of age-related dementias: implications for drug targets and approaches to effective therapeutics.
Kevin Mullane, Michael Williams

Curr Opin Pharmacol· February 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Alzheimer's disease (AD) therapeutics - 2: Beyond amyloid - Re-defining AD and its causality to discover effective therapeutics.
Kevin Mullane, Michael Williams

Biochem Pharmacol· December 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Alzheimer's disease (AD) therapeutics - 1: Repeated clinical failures continue to question the amyloid hypothesis of AD and the current understanding of AD causality.
Kevin Mullane, Michael Williams

Biochem Pharmacol· December 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Manipulating cell fate while confronting reproducibility concerns.
Jeannette M Osterloh, Kevin Mullane

Biochem Pharmacol· May 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Enhancing reproducibility: Failures from Reproducibility Initiatives underline core challenges.
Kevin Mullane, Michael Williams

Biochem Pharmacol· August 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The academic-industrial complex: navigating the translational and cultural divide.
Stephen Freedman, Kevin Mullane

Drug Discov Today· July 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Guidelines for manuscript submission in the peer-reviewed pharmacological literature.
Kevin Mullane, S J Enna, Jacques Piette, Michael Williams

Biochem Pharmacol· October 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Unknown unknowns in biomedical research: does an inability to deal with ambiguity contribute to issues of irreproducibility?
Kevin Mullane, Michael Williams

Biochem Pharmacol· September 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Animal models of asthma: reprise or reboot?
Kevin Mullane, Michael Williams

Biochem Pharmacol· January 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The fall and rise of pharmacology--(re-)defining the discipline?
Raymond J Winquist, Kevin Mullane, Michael Williams

Biochem Pharmacol· January 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Translational paradigms in pharmacology and drug discovery.
Kevin Mullane, Raymond J Winquist, Michael Williams

Biochem Pharmacol· January 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacology in 21st century biomedical research. Preface.
Kevin Mullane, Michael Williams, Raymond Winquist

Biochem Pharmacol· January 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Replicated, replicable and relevant-target engagement and pharmacological experimentation in the 21st century.
Terry Kenakin, David B Bylund, Myron L Toews, Kevin Mullane, Raymond J Winquist

Biochem Pharmacol· January 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Alzheimer's therapeutics: continued clinical failures question the validity of the amyloid hypothesis-but what lies beyond?
Kevin Mullane, Michael Williams

Biochem Pharmacol· February 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Translational semantics and infrastructure: another search for the emperor's new clothes?
Kevin Mullane, Michael Williams

Drug Discov Today· May 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Asthma translational medicine: report card.
Kevin Mullane

Biochem Pharmacol· September 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The increasing challenge of discovering asthma drugs.
Kevin Mullane

Biochem Pharmacol· September 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Asthma therapeutics: recent strides, new hurdles.
Kevin Mullane

Mol Interv· April 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Defining clinically meaningful outcomes in the evaluation of new treatments for oral mucositis: oral mucositis patient provider advisory board.
Lisa A Bellm, Gail Cunningham, Laurie Durnell, June Eilers, Joel B Epstein, Kevin Mullane

Cancer Invest· September 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis